2014 Edition Certification Pricing and Transparency Statement
Tenzing VistA Inpatient and Ambulatory products are 2014 Edition compliant and have been certified by InfoGuard Laboratories, Inc., an ONC-ACB, in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.
- Vendor/Developer: Tenzing Medical LLC.
- Certified EHR Name: Tenzing VistA
- Certified EHR Version: 1.0
- InfoGard Certification #: xxxxxxx (inpatient) xxxxxxxx (ambulatory)
- Certification Date: xxxxxxxx (inpatient) xxxxxxxx (ambulatory)
Certification Criteria
170.314 (a)(1): Computerized provider order entry; 170.314 (a)(2): Drug-drug, drug-allergy interactions checks; 170.314 (a)(3): Demographics; 170.314 (a)(4): Vital signs, body mass index, and growth Charts; 170.314 (a)(5): Problem list; 170.314 (a)(6): Medication list; 170.314 (a)(7): Medication allergy list; 170.314 (a)(8): Clinical decision support; 170.314 (a)(9): Electronic notes; 170.314 (a)(10): Drug formulary checks; 170.314 (a)(11): Smoking status; 170.314 (a)(12): Image results; 170.314 (a)(13): Family health history; 170.314 (a)(14): Patient list creation; 170.314 (a)(15): Patient-specific education resources; 170.314 (a)(16): Inpatient setting only - electronic medication administration record; 170.314 (a)(17): Advance directives; 170.314 (b)(1): Transitions of care - receive, display and incorporate transition of care/referral summaries; 170.314 (b)(2): Transitions of care - create and transmit transition of care/referral summaries; 170.314 (b)(3): Electronic prescribing; 170.314 (b)(4): Clinical information reconciliation; 170.314 (b)(5)(B): Incorporate laboratory tests and values/results; 170.314 (b)(6): Inpatient setting only - transmission of electronic laboratory tests and values/results to ambulatory providers; 170.314 (b)(7): Data portability; 170.314 (c)(1): Clinical quality measures - capture and export; 170.314 (c)(2): Clinical quality measures - import and calculate; 170.314 (c)(3): Clinical quality measures - electronic submission; 170.314 (d)(1): Authentication, access, control, and authorization; 170.314 (d)(2): Auditable events and tamper-resistance; 170.314 (d)(3): Audit report(s); 170.314 (d)(4): Amendments; 170.314 (d)(5): Automatic log-off; 170.314 (d)(6): Emergency access; 170.314 (d)(7): End-user device encryption; 170.314 (d)(8): Integrity; 170.314 (e)(1): View, download, and transmit to a 3rd party with edge protocol testing; 170.314 (e)(2) Ambulatory setting only – clinical summary; 170.314 (e)(3) Secure messaging – ambulatory setting only; 170.314 (f)(1): Immunization information; 170.314 (f)(2): Transmission to immunization registries; 170.314 (f)(3): Transmission to public health agencies - syndromic surveillance; 170.314 (f)(4): Inpatient setting only - transmission of reportable laboratory tests and values/results; 170.314 (g)(2): Automated measure calculation; 170.314 (g)(3): Safety-enhanced design; 170.314 (g)(4): Quality management system
Clinical Quality Measure: Ambulatory
CMS2: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plam; CMS56: Functional Status Assessment for Hip Replacement; CMS68: Documentation of Current Medications in the Medical Record; CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan; CMS75: Children Who Have Dental Decay or Cavities; CMS117: Childhood Immunization Status; CMS122: Diabetes: Hemoglobin A1c Poor Control; CMS123: Diabetes: Foot Exam; CMS126: Use of Appropriate Medications for Asthma; CMS136: ADHD: Follow-Up Care for Children Prescribed AttentionDeficit/Hyperactivi ty Disorder (ADHD) Medication; CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment; CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention; CMS146: Appropriate Testing for Children with Pharyngitis; CMS153: Chlamydia Screening for Women; CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI); CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents; CMS156: Use of High-Risk Medications in the Elderly; CMS159: Depression Remission at Twelve Months; CMS161: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment; CMS163: Diabetes: Low Density Lipoprotein (LDL) Management; CMS165: Controlling High Blood Pressure; CMS166: Use of Imaging Studies for Low Back Pain; CMS179: ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range
Clinical Quality Measure: Inpatient
CMS32: Median Time from ED Arrival to ED Departure for Discharged ED Patients; CMS55: Median Time from ED Arrival to ED Departure for Admitted ED Patients; CMS71: Anticoagulation Therapy for Atrial Fibrillation/Flutter; CMS72: Antithrombotic Therapy By End of Hospital Day 2; CMS73: Venous Thromboembolism Patients with Anticoagulation Overlap Therapy; CMS91: Thrombolytic Therapy; CMS102: Assessed for Rehabilitation; CMS104: Discharged on Antithrombotic Therapy; CMS107: Stroke Education; CMS108: Venous Thromboembolism Prophylaxis; CMS109: Venous Thromboembolism Patients Receiving Unfractionated Heparin with Dosages/Platelet Count Monitoring by Protocol or Nomogram; CMS110: Venous Thromboembolism Discharge Instructions; CMS111: Median Admit Decision Time to ED Departure Time for Admitted Patients; CMS114: Incidence of Potentially Preventable Venous Thromboembolism; CMS190: Intensive Care Unit Venous Thromboembolism Prophylaxis
Costs or Fees
Additional software required
- FDB MedKnowledge – Annual Fee Associated
- FDB MedsTracker – Annual Fee Associated
- JasperSoft – Open Source
- MedicaSoft Patient Portal – Annual Fee Associated
- MySQL – Open Source
- Mirth Interface Engine – Open Source
- popHealth – Open Source
- BarCode Medication Administration (BCMA) – Open Source
Contractual agreements, for third party products, are evaluated during contract discussions.
Tenzing VistA requires a contract with Tenzing Medical LLC for the implementation and operation of the software. Contracting is flexible based on need and costs associated with the installation, configuration and training of Tenzing VistA are dependent on the services and size of the organization. Annual support costs are dependent on the level of support for which the Organization choses to contract. Fees range depending on choice of minimal to full support. **
Limitations:
This product has no technical or practical limitations
More Information:
For more information on Tenzing VistA, please visit: http://tenzingmedical.com/onc-cert
** Foregoing subject to change